Stockreport

Opthea to Present at the OIS Retina Innovation Summit at ARVO

Opthea Limited - American Depositary Shares  (OPT) 
PDF MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutic [Read more]